Pure Global
NCT05862350

Effects of Lavender Essential Oil in Patients With Chronic Heart Failure

Effects of Lavender Essential Oil on Sleep Quality, Anxiety, and Fatigue in Patients With Chronic Heart Failure
First Affiliated Hospital Xi'an Jiaotong University·ClinicalTrials.gov·otherNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Chronic Heart Failure
Drug/Device/Intervention
aromatherapy inhalation with lavender essential oil
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
First Affiliated Hospital Xi'an Jiaotong University
Timeline & enrollment
Phase
N/A
Start date
May 10, 2023
End date
Oct 30, 2023
Enrollment
60 participants
Primary outcome

Change of Pittsburgh Sleep Quality Index,Change of State-trait anxiety inventory,Change of the Fatigue Assessment Scale

Summary

The goal of the trial is to study the effects of lavender essential oil on sleep quality,
 anxiety, and fatigue in patients with chronic heart failure. The main questions it may answer
 are
 
 1. effects of lavender essential oil on sleep quality
 
 2. effects of lavender essential oil on anxiety
 
 3. effects of lavender essential oil on fatigue
 
 Patients will be randomly divided into experimental and control groups, the control group
 will inhale essential coconut oil, and the experimental group will inhale lavender essential
 oil for four weeks. At baseline, on the 7th day, and 28th day, the sleep quality, anxiety,
 and fatigue will be evaluated.

ICD-10 classifications
Heart failureHeart failure, unspecifiedCongestive heart failureHypertensive heart disease with (congestive) heart failureHypertensive heart disease without (congestive) heart failure
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05862350
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05862350 through Pure Global AI's free database. This phase not specified trial is sponsored by First Affiliated Hospital Xi'an Jiaotong University and is currently Not yet recruiting. The study focuses on Chronic Heart Failure. Target enrollment is 60 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.